Literature DB >> 29523389

Postural tachycardia syndrome - Diagnosis, physiology, and prognosis.

Amy C Arnold1, Jessica Ng2, Satish R Raj3.   

Abstract

Postural tachycardia syndrome (POTS) is a heterogeneous clinical syndrome that has gained increasing interest over the past few decades due to its increasing prevalence and clinical impact on health-related quality of life. POTS is clinically characterized by sustained excessive tachycardia upon standing that occurs in the absence of significant orthostatic hypotension and other medical conditions and or medications, and with chronic symptoms of orthostatic intolerance. POTS represents one of the most common presentations of syncope and presyncope secondary to autonomic dysfunction in emergency rooms and in cardiology, neurology, and primary care clinics. The most sensitive method to detect POTS is a detailed medical history, physical examination with orthostatic vital signs or brief tilt table test, and a resting 12-lead electrocardiogram. Additional diagnostic testing may be warranted in selected patients based on clinical signs. While the precise etiology remains unknown, the orthostatic tachycardia in POTS is thought to reflect convergence of multiple pathophysiological processes, as a final common pathway. Based on this, POTS is often described as a clinical syndrome consisting of multiple heterogeneous disorders, with several underlying pathophysiological processes proposed in the literature including partial sympathetic neuropathy, hyperadrenergic state, hypovolemia, mast cell activation, deconditioning, and immune-mediated. These clinical features often overlap, however, making it difficult to categorize individual patients. Importantly, POTS is not associated with mortality, with many patients improving to some degree over time after diagnosis and proper treatment. This review will outline the current understanding of diagnosis, pathophysiology, and prognosis in POTS.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnosis; Etiology; Orthostatic intolerance; Postural tachycardia syndrome

Mesh:

Year:  2018        PMID: 29523389      PMCID: PMC6113123          DOI: 10.1016/j.autneu.2018.02.005

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  75 in total

1.  Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects.

Authors:  Julian M Stewart
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

2.  Refining patterns of joint hypermobility, habitus, and orthopedic traits in joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type.

Authors:  Silvia Morlino; Chiara Dordoni; Isabella Sperduti; Marina Venturini; Claudia Celletti; Filippo Camerota; Marina Colombi; Marco Castori
Journal:  Am J Med Genet A       Date:  2017-03-07       Impact factor: 2.802

3.  Orthostatic heart rate responses after prolonged space flights.

Authors:  Jens Tank; Roman M Baevsky; Irina I Funtova; André Diedrich; Irina N Slepchenkova; Jens Jordan
Journal:  Clin Auton Res       Date:  2010-12-25       Impact factor: 4.435

4.  Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

Authors:  Roy Freeman; Wouter Wieling; Felicia B Axelrod; David G Benditt; Eduardo Benarroch; Italo Biaggioni; William P Cheshire; Thomas Chelimsky; Pietro Cortelli; Christopher H Gibbons; David S Goldstein; Roger Hainsworth; Max J Hilz; Giris Jacob; Horacio Kaufmann; Jens Jordan; Lewis A Lipsitz; Benjamin D Levine; Phillip A Low; Christopher Mathias; Satish R Raj; David Robertson; Paola Sandroni; Irwin Schatz; Ron Schondorff; Julian M Stewart; J Gert van Dijk
Journal:  Clin Auton Res       Date:  2011-04       Impact factor: 4.435

5.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

6.  Exercise performance in adolescents with autonomic dysfunction.

Authors:  Barbara E U Burkhardt; Phil R Fischer; Chad K Brands; Co-burn J Porter; Amy L Weaver; Paul J Yim; Paolo T Pianosi
Journal:  J Pediatr       Date:  2010-09-01       Impact factor: 4.406

7.  Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia.

Authors:  G Jacob; J R Shannon; B Black; I Biaggioni; R Mosqueda-Garcia; R M Robertson; D Robertson
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

8.  Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers.

Authors:  Cindy C Lai; Philip R Fischer; Chad K Brands; Jennifer L Fisher; Co-Burn J Porter; Sherilyn W Driscoll; Kevin K Graner
Journal:  Pacing Clin Electrophysiol       Date:  2009-02       Impact factor: 1.976

9.  Quality of life in patients with postural tachycardia syndrome.

Authors:  Lisa M Benrud-Larson; Melanie S Dewar; Paola Sandroni; Teresa A Rummans; Jennifer A Haythornthwaite; Phillip A Low
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616

10.  The Postural Tachycardia Syndrome (POTS): pathophysiology, diagnosis & management.

Authors:  Satish R Raj
Journal:  Indian Pacing Electrophysiol J       Date:  2006-04-01
View more
  41 in total

1.  Attention and executive function are impaired during active standing in postural tachycardia syndrome.

Authors:  Amanda J Miller; Timothy Sheehan; Kate M Bourne; Monica Feeley; Amy C Arnold
Journal:  Auton Neurosci       Date:  2020-06-06       Impact factor: 3.145

Review 2.  Moving from the present to the future of Postural Tachycardia Syndrome - What we need.

Authors:  Satish R Raj; David Robertson
Journal:  Auton Neurosci       Date:  2018-07-04       Impact factor: 3.145

Review 3.  The challenges of chronic pain and fatigue.

Authors:  Jessica A Eccles; Kevin A Davies
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

4.  Editorial: Autonomic Neuropathy and Cardiovascular Disease in Aging.

Authors:  A Shams; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

5.  Riggs-type dominant congenital stationary night blindness: ERG findings, a new GNAT1 mutation and a systemic association.

Authors:  Michael F Marmor; Christina Zeitz
Journal:  Doc Ophthalmol       Date:  2018-07-26       Impact factor: 2.379

6.  Orthostatic leg pain in neuropathic postural tachycardia syndrome: what does muscle excitability have to do with it?

Authors:  Amy C Arnold; Judith Navarro-Otano
Journal:  Clin Auton Res       Date:  2021-11-12       Impact factor: 4.435

7.  Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome.

Authors:  Emily M Garland; Alfredo Gamboa; Victor C Nwazue; Jorge E Celedonio; Sachin Y Paranjape; Bonnie K Black; Luis E Okamoto; Cyndya A Shibao; Italo Biaggioni; David Robertson; André Diedrich; William D Dupont; Satish R Raj
Journal:  J Am Coll Cardiol       Date:  2021-05-04       Impact factor: 24.094

Review 8.  Cardiovascular Disorders Mediated by Autonomic Nervous System Dysfunction.

Authors:  Pravin Khemani; Ali A Mehdirad
Journal:  Cardiol Rev       Date:  2020 Mar/Apr       Impact factor: 3.109

9.  Synergistic but separable sensory changes in postural tachycardia syndrome and chronic migraine.

Authors:  Melissa M Cortez; Leah Millsap; K C Brennan
Journal:  Clin Auton Res       Date:  2020-11-10       Impact factor: 4.435

10.  Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1.

Authors:  Steven Vernino; Kate M Bourne; Lauren E Stiles; Blair P Grubb; Artur Fedorowski; Julian M Stewart; Amy C Arnold; Laura A Pace; Jonas Axelsson; Jeffrey R Boris; Jeffrey P Moak; Brent P Goodman; Kamal R Chémali; Tae H Chung; David S Goldstein; Andre Diedrich; Mitchell G Miglis; Melissa M Cortez; Amanda J Miller; Roy Freeman; Italo Biaggioni; Peter C Rowe; Robert S Sheldon; Cyndya A Shibao; David M Systrom; Glen A Cook; Taylor A Doherty; Hasan I Abdallah; Anil Darbari; Satish R Raj
Journal:  Auton Neurosci       Date:  2021-06-05       Impact factor: 2.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.